CoChat
Sign Up
Cited by 35

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes

Scott, Matthew L., Coleman, David T., Kelly, Kinsey C., Carroll, Jennifer L., Woodby, Brittany, Songock, William K., Cardelli, James A., Bodily, Jason M.·2018·Virology
DOI 10.1016/j.virol.2018.03.021PMC PMC5971161
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.virol.2018.03.021

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 78

  1. Accornero, 2012, Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells, PLoS One, 7, e44982, 10.1371/journal.pone.0044982 · DOI
  2. Baker, 1987, Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines, J. Virol., 61, 962, 10.1128/jvi.61.4.962-971.1987 · DOI
  3. Barbaresi, 2010, Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain, J. Gen. Virol., 91, 521, 10.1099/vir.0.016295-0 · DOI
  4. Baykal, 2003, Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas, Gynecol. Oncol., 88, 123, 10.1016/S0090-8258(02)00073-2 · DOI
  5. Bergstrom, 2000, Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells, Exp. Cell Res., 259, 293, 10.1006/excr.2000.4967 · DOI
  6. Boccaccio, 2006, Invasive growth: a MET-driven genetic programme for cancer and stem cells, Nat. Rev. Cancer, 6, 637, 10.1038/nrc1912 · DOI
  7. Bodily, 2013, Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle, Virology, 443, 11, 10.1016/j.virol.2013.04.033 · DOI
  8. Bodily, 2011, The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle, J. Virol., 85, 8852, 10.1128/JVI.00664-11 · DOI
  9. Bodily, 2011, Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases, Cancer Res., 71, 1187, 10.1158/0008-5472.CAN-10-2626 · DOI · Paper page
  10. Bonine-Summers, 2007, Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells, Cancer Biol. Ther., 6, 561, 10.4161/cbt.6.4.3851 · DOI
  11. Caberg, 2008, Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes, Carcinogenesis, 29, 1441, 10.1093/carcin/bgn145 · DOI
  12. Charette, 2007, The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner, Oncogene, 26, 7386, 10.1038/sj.onc.1210541 · DOI
  13. Cheng, 2012, The role of human papillomavirus type 16 E6/E7 oncoproteins in cervical epithelial-mesenchymal transition and carcinogenesis, Oncol. Lett., 3, 667, 10.3892/ol.2011.512 · DOI
  14. Cheung, 2013, Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome, Gynecol. Oncol., 131, 374, 10.1016/j.ygyno.2013.08.026 · DOI
  15. Chmielowiec, 2007, c-Met is essential for wound healing in the skin, J. Cell Biol., 177, 151, 10.1083/jcb.200701086 · DOI
  16. Cirri, 2012, Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression, Cancer Metastas. Rev., 31, 195, 10.1007/s10555-011-9340-x · DOI
  17. D'Costa, 2012, Transcriptional repression of E-cadherin by human papillomavirus type 16 E6, PLoS One, 7, e48954, 10.1371/journal.pone.0048954 · DOI · Paper page
  18. den Boon, 2015, Molecular transitions from papillomavirus infection to cervical precancer and cancer: role of stromal estrogen receptor signaling, Proc. Natl. Acad. Sci. USA, 112, E3255, 10.1073/pnas.1509322112 · DOI
  19. Dimaio, 2013, The E5 proteins, Virology, 445, 99, 10.1016/j.virol.2013.05.006 · DOI
  20. Doorbar, 2015, Human papillomavirus molecular biology and disease association, Rev. Med. Virol., 25, 2, 10.1002/rmv.1822 · DOI
  21. Doorbar, 2012, The biology and life-cycle of human papillomaviruses, Vaccine, 30, F55, 10.1016/j.vaccine.2012.06.083 · DOI
  22. Drake, 2014, Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again?, J. Pathol., 232, 283, 10.1002/path.4298 · DOI
  23. Duffy, 2003, Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6, Virology, 314, 196, 10.1016/S0042-6822(03)00390-8 · DOI
  24. Egawa, 2017, The low-risk papillomaviruses, Virus Res., 231, 119, 10.1016/j.virusres.2016.12.017 · DOI
  25. Faghihloo, 2016, Transcriptional regulation of E-cadherin and oncoprotein E7 by valproic acid in HPV positive cell lines, Iran. J. Basic Med. Sci., 19, 601
  26. Fehrmann, 2003, Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation, J. Virol., 77, 2819, 10.1128/JVI.77.5.2819-2831.2003 · DOI
  27. Gambarotta, 1996, Ets up-regulates MET transcription, Oncogene, 13, 1911
  28. Geiger, 2008, Anomalous features of EMT during keratinocyte transformation, PLoS One, 3, e1574, 10.1371/journal.pone.0001574 · DOI
  29. Genther, 2003, Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle, J. Virol., 77, 2832, 10.1128/JVI.77.5.2832-2842.2003 · DOI
  30. Genther Williams, 2005, Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene, Cancer Res., 65, 6534, 10.1158/0008-5472.CAN-05-0083 · DOI · Paper page
  31. Gherardi, 2012, Targeting MET in cancer: rationale and progress, Nat. Rev. Cancer, 12, 89, 10.1038/nrc3205 · DOI
  32. Gius, 2007, Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates, Cancer Res., 67, 7113, 10.1158/0008-5472.CAN-07-0260 · DOI
  33. Greco, 2011, Human papillomavirus 16 E5 modulates the expression of host microRNAs, PLoS One, 6, e21646, 10.1371/journal.pone.0021646 · DOI
  34. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  35. Hellner, 2009, HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition, Virology, 391, 57, 10.1016/j.virol.2009.05.036 · DOI · Paper page
  36. Howie, 2009, Papillomavirus E6 proteins, Virology, 384, 324, 10.1016/j.virol.2008.11.017 · DOI
  37. Hsieh, 2000, Sequence variants and functional analysis of human papillomavirus type 16 E5 gene in clinical specimens, Arch. Virol., 145, 2273, 10.1007/s007050070020 · DOI
  38. Hwang, 2011, Wild-type p53 controls cell motility and invasion by dual regulation of MET expression, Proc. Natl. Acad. Sci. USA, 108, 14240, 10.1073/pnas.1017536108 · DOI
  39. Jung, 2013, A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition, Biochem. Biophys. Res. Commun., 435, 339, 10.1016/j.bbrc.2013.04.060 · DOI
  40. Kankuri, 2005, Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness, Cancer Res., 65, 9914, 10.1158/0008-5472.CAN-05-1559 · DOI
  41. Klingelhutz, 2012, Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses, Virology, 424, 77, 10.1016/j.virol.2011.12.018 · DOI
  42. Kristiansen, 1994, Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix, J. Clin. Pathol., 47, 253, 10.1136/jcp.47.3.253 · DOI
  43. Latorre, 2005, Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells, J. Cell Sci., 118, 4283, 10.1242/jcs.02560 · DOI
  44. Lee, 2008, Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation, Clin. Cancer Res., 14, 4743, 10.1158/1078-0432.CCR-08-0234 · DOI
  45. Liao, 2013, Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo, Oncol. Rep., 29, 95, 10.3892/or.2012.2106 · DOI
  46. Lopes-Bastos, 2016, Tumour-endothelial cell communications: important and indispensable mediators of tumour angiogenesis, Anticancer Res., 36, 1119
  47. Matsumoto, 2006, Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions, Int. J. Cancer, 119, 477, 10.1002/ijc.21808 · DOI
  48. Maufort, 2010, A role for HPV16 E5 in cervical carcinogenesis, Cancer Res., 70, 2924, 10.1158/0008-5472.CAN-09-3436 · DOI · Paper page
  49. McBride, 2017, The role of integration in oncogenic progression of HPV-associated cancers, PLoS Pathog., 13, e1006211, 10.1371/journal.ppat.1006211 · DOI · Paper page
  50. Moody, 2010, Human papillomavirus oncoproteins: pathways to transformation, Nat. Rev., 10, 550, 10.1038/nrc2886 · DOI
  51. Munger, 2004, Mechanisms of human papillomavirus-induced oncogenesis, J. Virol., 78, 11451, 10.1128/JVI.78.21.11451-11460.2004 · DOI · Paper page
  52. Myong, 2012, Loss of E-cadherin and acquisition of vimentin in epithelial-mesenchymal transition are notable indicators of uterine cervix cancer progression, Korean J. Pathol., 46, 341, 10.4132/KoreanJPathol.2012.46.4.341 · DOI
  53. Nakamura, 2009, Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses, Virology, 387, 442, 10.1016/j.virol.2009.02.036 · DOI
  54. Nees, 2000, Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes, Cancer Res., 60, 4289
  55. Parkin, 2006, Chapter 2: The burden of HPV-related cancers, Vaccine, 24, S11, 10.1016/j.vaccine.2006.05.111 · DOI
  56. Patel, 1999, The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300, EMBO J., 18, 5061, 10.1093/emboj/18.18.5061 · DOI · Paper page
  57. Pett, 2007, Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?, J. Pathol., 212, 356, 10.1002/path.2192 · DOI
  58. Pim, 2002, Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins, Oncogene, 21, 8140, 10.1038/sj.onc.1206026 · DOI
  59. Roman, 2013, The papillomavirus E7 proteins, Virology, 445, 138, 10.1016/j.virol.2013.04.013 · DOI
  60. Sahab, 2012, Quantitative measurement of human papillomavirus type 16 E5 oncoprotein levels in epithelial cell lines by mass spectrometry, J. Virol., 86, 9465, 10.1128/JVI.01032-12 · DOI · Paper page
  61. Schwarz, 1985, Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature, 314, 111, 10.1038/314111a0 · DOI
  62. Seol, 2000, Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1, Oncogene, 19, 1132, 10.1038/sj.onc.1203404 · DOI
  63. Shimabukuro, 2001, Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer, Gynecol. Oncol., 83, 205, 10.1006/gyno.2001.6347 · DOI
  64. Spurgeon, 2017, Human papillomavirus and the stroma: bidirectional crosstalk during the virus life cycle and carcinogenesis, Viruses, 9, 10.3390/v9080219 · DOI
  65. Steele, 2002, Variable expression of some "housekeeping" genes during human keratinocyte differentiation, Anal. Biochem., 307, 341, 10.1016/S0003-2697(02)00045-3 · DOI
  66. Steffan, 2011, The HGF-met signaling axis: emerging themes and targets of inhibition, Curr. Protein Pept. Sci., 12, 12, 10.2174/138920311795659425 · DOI
  67. Thiery, 2006, Complex networks orchestrate epithelial-mesenchymal transitions, Nat. Rev. Mol. Cell Biol., 7, 131, 10.1038/nrm1835 · DOI
  68. Trusolino, 2010, MET signalling: principles and functions in development, organ regeneration and cancer, Nat. Rev. Mol. Cell Biol., 11, 834, 10.1038/nrm3012 · DOI
  69. Tummers, 2015, The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFkappaB activation, Nat. Commun., 6, 6537, 10.1038/ncomms7537 · DOI
  70. Velpula, 2012, EGFR and c-met cross talk in glioblastoma and its regulation by human cord blood stem cells, Transl. Oncol., 5, 379, 10.1593/tlo.12235 · DOI · Paper page
  71. Venuti, 2011, Papillomavirus E5: the smallest oncoprotein with many functions, Mol. Cancer, 10, 140, 10.1186/1476-4598-10-140 · DOI
  72. Walker, 2003, Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus, Clin. Cancer Res., 9, 273
  73. Wilson, 2005, Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose, Methods Mol. Med., 119, 157
  74. Woodby, 2016, The interaction Between human papillomaviruses and the stromal microenvironment, Prog. Mol. Biol. Transl. Sci., 144, 169, 10.1016/bs.pmbts.2016.09.003 · DOI
  75. Woodman, 2007, The natural history of cervical HPV infection: unresolved issues, Nat. Rev. Cancer, 7, 11, 10.1038/nrc2050 · DOI
  76. Zhang, Y., Wu, J.Z., Yang, Y.Q., Ma, R., Zhang, J.Y., Feng, J.F., 2014. Expression of growthregulated oncogene1, hepatocyte growth factor, plateletderived growth factorAA and soluble Eselectin and their association with highrisk human papillomavirus infection in squamous cell carcinoma of the uterine cervix. Molecular Medicine Reports. · DOI
  77. zur Hausen, 1996, Papillomavirus infections--a major cause of human cancers, Biochim. Biophys. Acta, 1288, F55
  78. zur Hausen, 2009, Papillomaviruses in the causation of human cancers - a brief historical account, Virology, 384, 260, 10.1016/j.virol.2008.11.046 · DOI · Paper page

Cited by

Metadata

Authors
Scott, M. L., Coleman, D. T., Kelly, K. C., Carroll, J. L., Woodby, B., Songock, W. K., Cardelli, J. A., & Bodily, J. M.
Venue
Virology
Publisher
Elsevier BV
Published
2018-06
Volume
519
Pages
1-11
ISSN
0042-6822
DOI
10.1016/j.virol.2018.03.021
PMC
PMC5971161
Cited by
35
References
2
Language
en
Licence
Funders
  • National Institute of General Medical Sciences (P30-GM110703)
  • National Institute of Allergy and Infectious Diseases (R01AI118904)
  • LSUHSC Research Council
  • Feist-Weiller Cancer Center
  • Biomedical Research Foundation
  • National Institutes of Health (8 P20 GM103433, R01AI118904)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review